Thrive Capital Partners III Amends Oscar Health Stake
Ticker: OSCR · Form: SC 13D/A · Filed: Nov 13, 2024 · CIK: 1568651
Sentiment: neutral
Topics: shareholder-filing, ownership-change, sec-filing
Related Tickers: OSCR
TL;DR
Thrive Capital Partners III just updated their Oscar Health stake filing - watch for news.
AI Summary
Thrive Capital Partners III, L.P. and its affiliates have filed an amendment to their Schedule 13D, reporting a change in beneficial ownership of Oscar Health, Inc. as of November 13, 2024. The filing indicates a shift in their stake, though the exact percentage and number of shares are not detailed in this excerpt. The filing also lists Joshua Kushner as a group member.
Why It Matters
Changes in significant shareholder filings like this can signal shifts in investor sentiment or strategy, potentially impacting Oscar Health's stock price and corporate governance.
Risk Assessment
Risk Level: medium — Schedule 13D filings indicate significant ownership changes by large investors, which can lead to market volatility.
Key Players & Entities
- Thrive Capital Partners III, L.P. (company) — Filing entity
- Oscar Health, Inc. (company) — Subject company
- Joshua Kushner (person) — Group member
- 20241113 (date) — Filing date
FAQ
What specific change in beneficial ownership is reported in this SC 13D/A filing?
The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership, but the specific details of the change (e.g., number of shares, percentage) are not provided in this excerpt.
Who are the group members listed in this filing?
The group members listed include CLAREMOUNT TW, L.P, CLAREMOUNT V ASSOCIATES, L.P, CLAREMOUNT VI ASSOCIATES, L.P., CLAREMOUNT VII ASSOCIATES, L.P., JOSHUA KUSHNER, THRIVE CAPITAL PARTNERS II, L.P., THRIVE CAPITAL PARTNERS V, L.P, THRIVE CAPITAL PARTNERS VI GROWTH, L.P., THRIVE CAPITAL PARTNERS VII GROWTH, L.P., THRIVE PARTNERS II GP, LLC, THRIVE PARTNERS III GP, LLC, THRIVE PARTNERS V GP, LLC, THRIVE PARTNERS VI GP, LLC, THRIVE PARTNERS VII GP, LLC, and THRIVE PARTNERS VII GROWTH GP, LLC.
What is the filing date of this SC 13D/A amendment?
The filing date is November 13, 2024.
What is the primary business of Oscar Health, Inc. according to the filing?
Oscar Health, Inc. is in the HOSPITAL & MEDICAL SERVICE PLANS industry, with SIC code 6324.
What is the business address of Thrive Capital Partners III, L.P.?
The business address of Thrive Capital Partners III, L.P. is 295 Lafayette Street, New York, NY 10012.
Filing Stats: 4,665 words · 19 min read · ~16 pages · Grade level 15.7 · Accepted 2024-11-13 21:24:55
Key Financial Figures
- $0.00001 — Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class o
- $187,582,285 — tem 5 for an aggregate of approximately $187,582,285, using funds from working capital. In a
- $35,000,000 — and Claremount VII agreed to purchase, $35,000,000 in the aggregate principal amount of th
Filing Documents
- d877238dsc13da.htm (SC 13D/A) — 258KB
- 0001193125-24-257647.txt ( ) — 260KB
of the Schedule 13D is hereby amended and restated as follows
Item 3 of the Schedule 13D is hereby amended and restated as follows: The Thrive Capital Funds purchased the shares of Common Stock set forth in Item 5 for an aggregate of approximately $187,582,285, using funds from working capital. In addition, on January 27, 2022, pursuant to the Investment Agreement previously described in Item 6 of this statement, the Company agreed to issue and sell to Thrive Capital Partners VII Growth, L.P. ( Thrive VII Growth ) and Claremount VII Associates, L.P. ( Claremount VII ), and Thrive VII Growth and Claremount VII agreed to purchase, $35,000,000 in the aggregate principal amount of the Companys 7.25% Convertible Senior Notes due 2031 (the Convertible Notes or Notes ) using funds from working capital. The information set forth in Item 4 and Item 5(c) below is incorporated by reference in its entirety into this Item 3. ITEM5. INTEREST IN SECURITIES OF THE ISSUER
of the Schedule 13D is hereby amended and restated as follows
Item 5 of the Schedule 13D is hereby amended and restated as follows: (a)-(b) The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the Exchange Act ), the percent of class was calculated based on (i) 211,754,816 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuers Quarterly Report on Form 10-Q as filed by the Issuer with the SEC on November 7, 2024, (ii) the shares, if any, of Class A Common Stock underlying Convertible Notes beneficially owned by the reporting person and (iii) the shares, if any, of Class B Common Stock of the Issuer beneficially owned by the reporting person (with such shares treated as converted into shares of Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to the Exchange Act). Thrive Capital Partners II, L.P. ( Thrive II ) directly holds 6,103,319 shares of Class B common stock. Thrive Partners II GP, LLC ( Thrive Partners II ), as the general partner of Thrive II, may be deemed to beneficially own the shares directly held Thrive II. Thrive Capital Partners III, L.P. ( Thrive III ) directly holds 22,391,068 shares of Class B common stock and Claremount TW, L.P. ( Claremount TW ) directly holds 757,239 shares of Class B common stock. Thrive Partners III GP, LLC ( Thrive Partners III ), as the general partner of Thrive III and Claremount TW, may be deemed to beneficially own the shares directly held Thrive III and Claremount TW. Thrive Capital Partners V, L.P. ( Thrive V ) directly holds 1,040,704 shares of Class B common stock and Claremount V Associates, L.P. ( Claremount V ) directly holds 19,239 shares of Class B common stock. Thrive Partners V GP, LLC ( Thrive Partners V ), as the general partner of Thrive V and Claremount V, may be deemed to beneficially own the shares directly held Thrive V and